ARX201
- Generic Name
- ARX201
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- -
- Background
ARX201 (PEG-ahGH) is a recombinant form of human growth hormone that has been modified using Ambrx’s patented ReCODE™ technology to achieve precise spatial positioning of the site of polyethylene glycol (PEG) attachment to human growth hormone, by biosynthetic incorporation of a chemically unique amino acid (ahGH). ARX201 has improved pharmacological propert...
- Indication
Investigated for use/treatment in growth hormone deficiencies/abnormalities.
- Associated Conditions
- -
- Associated Therapies
- -
Safety, Tolerability and PK/PD Study in Young Adult Patients With Childhood Onset Growth Hormone Deficiency (GHD).
- First Posted Date
- 2008-10-23
- Last Posted Date
- 2009-10-12
- Lead Sponsor
- Ambrx, Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT00778518
- Locations
- 🇭🇺
Accelsiors CRO and Consultancy Services, Budapest, Hungary
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath